Accessibility settings

This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (728) Design and Usability of Medical Devices (157) Development of Novel Medical Devices and Innovations for Existing Devices (113) Intensive Care Unit (ICU) (167) Research Infrastructures and Registries (82) Outcomes Research in Perioperative Medicine (49)

Published on in Vol 13 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/55880, first published .
The COSMOS Registry of CytoSorb Hemoadsorption Therapy in Critically Ill Patients: Protocol for an International, Prospective Registry

The COSMOS Registry of CytoSorb Hemoadsorption Therapy in Critically Ill Patients: Protocol for an International, Prospective Registry

The COSMOS Registry of CytoSorb Hemoadsorption Therapy in Critically Ill Patients: Protocol for an International, Prospective Registry

Authors of this article:

Fabio Silvio Taccone1 Author Orcid Image ;   Frank Martin Brunkhorst2 Author Orcid Image ;   Gabriella Bottari3 Author Orcid Image ;   Jorge Hidalgo4 Author Orcid Image ;   Andreas Kribben5 Author Orcid Image ;   Jean-Louis Teboul6 Author Orcid Image ;   Dana Tomescu7 Author Orcid Image ;   Teresa Klaus8 Author Orcid Image ;   Joerg Scheier8 Author Orcid Image ;   Efthymios Deliargyris9 Author Orcid Image ;   Ricard Ferrer10 Author Orcid Image
Article Authors Cited by (9) Tweetations (2) Metrics

Journals

  1. Lingappa K, Chatterjee S. CytoSorb® as the Rescue Therapy of Acute Respiratory Distress Syndrome and Shock in a Case of Severe Pancreatitis. Indian Journal of Critical Care Case Report 2025;4(3):61 View
  2. Ceschia G, Longo G, Igeno J, Vidal E. Technicalities, current evidence, and clinical indications of hemoadsorption in critically ill children. Pediatric Nephrology 2026;41(3):649 View
  3. Guarino M, Costanzini A, Luppi F, Maritati M, Contini C, De Giorgio R, Spampinato M. Extracorporeal Cytokine Adsorption in Sepsis: Current Evidence and Future Perspectives. Biomedicines 2025;13(7):1684 View
  4. Barbura N, Porosnicu T, Papurica M, Badea M, Bedreag O, Bratosin F, Lazureanu V. Continuous Hemofiltration During Extracorporeal Membrane Oxygenation in Adult Septic Shock: A Comparative Cohort Analysis. Biomedicines 2025;13(8):1829 View
  5. Barkat M, Li Q, Manzoor M, Xu C, Hussain N, Salawi A, Yang H, Hussain M. Sepsis-induced ALI/ARDS beyond supportive care: molecular mechanisms and cutting-edge therapies. International Immunopharmacology 2025;166:115495 View
  6. De Rosa S, Ferrari F, Zarantonello D, Dalpiaz A, Lassola S. Cast nephropathy in the ICU: Early recognition and extracorporeal strategies to improve outcomes. Journal of Intensive Medicine 2025 View
  7. Ferrer R, Tyczynski B, Kreutz J, Scharf C, Thielmann M, Bellgardt M, Kribben A, Hohlstein P, Germano N, Henzler D, Baumann A, Unglaube M, Guenther U, Fan W, Klaus T, Humbert V, Scheier J, Deliargyris E, Taccone F. Hemoadsorption therapy in severe rhabdomyolysis: a report from the international, prospective COSMOS (CytOSorb ® TreatMent of Critically ill PatientS) registry. Renal Failure 2025;47(1) View
  8. Ferrer R, Thielmann M, Unglaube M, Kirschning T, Baumann A, Kreutz J, Kribben A, Tyczynski B, Guenther U, Henzler D, Scharf C, Germano N, Bellgardt M, El-Essawi A, Hohlstein P, Guenther T, Schulze P, Aucella F, Fernandez M, Koestenberger M, Bottari G, Hidalgo J, Teboul J, Tomescu D, Klaus T, Fan W, Scheier J, Deliargyris E, Taccone F. The international, prospective COSMOS (CytOSorb® TreatMent Of Critically Ill PatientS) Registry: results from the first 300 patients. Journal of Anesthesia, Analgesia and Critical Care 2026;6(1) View
  9. Cutuli S, Lassola S, Philippe R, De Rosa S. Clinical applications of oXiris membranes: Targeting inflammation and renal dysfunction in ICU patients. Journal of Intensive Medicine 2026 View